• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET Back to Search Results
Model Number 10220
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bacterial Infection (1735); Low Blood Pressure/ Hypotension (1914)
Event Date 08/19/2022
Event Type  Injury  
Event Description
The journal article, 'therapeutic plasma exchange: a potential therapeutic modality for critically ill adults with severe acute respiratory syndrome coronavirus 2 infection', describes a retrospective analysis on covid-19 patients admitted to the intensive care unit and treated with therapeutic plasma exchange (tpe) from april 17, 2020 to july 2, 2020.A total of 95 patients were included, among whom 47% (n = 45) received tpe.In terms of tpe safety in the cohort, decreased arterial blood pressure was reported in 4.1% (n = 5) of procedures, of which 3.0% (n = 4) required vasopressors support.Potential line related infections were detected in 13% (n = 6) of the patients.The article does not provide patient details, therefore this report is being submitted as a summary of events.The disposable sets are not available for return for evaluation.
 
Manufacturer Narrative
Lot number, expiry and manufacture dates are not available.Investigation is in process, a follow-up report will be provided.Article citation: al-hashami, sabria,khamis, faryal,al-yahyay, maha,al-dowaiki, samata,al-mashaykhi, louza,al-khalili, huda,chandwani, juhi,al-salmi, issa,al-zakwani, ibrahim (2022).Therapeutic plasma exchange: a potential therapeutic modality for critically ill adults with severe acute respiratory syndrome coronavirus 2 infection journal of clinical apheresis, n/a(n/a), e-pub, ahead of print.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA EXCHANGE SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer (Section G)
TERUMO BCT
10810 w. collins ave
lakewood CO 80215
Manufacturer Contact
scot hilden
10810 w. collins ave
lakewood, CO 80215
MDR Report Key15625821
MDR Text Key301935179
Report Number1722028-2022-00343
Device Sequence Number1
Product Code GKT
UDI-Device Identifier05020583102200
UDI-Public05020583102200
Combination Product (y/n)N
Reporter Country CodeMU
PMA/PMN Number
BK150251
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 10/18/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number10220
Device Catalogue Number10220
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/23/2022
Initial Date FDA Received10/18/2022
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-